Image source: Shutterstock

Highlights

  • Deal completed through issuance of 101.5 million Class A ordinary shares.
  • Ucare platform integrates generative AI with data from over 4,000 hospitals.
  • AI tools to be embedded into TRX’s underwriting and claims processing systems 

 

TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) has completed the acquisition of Ucare Inc., a developer of AI-based health insurance risk management systems, in an all-stock transaction valued at USD150 million. The deal includes the issuance of 101,486,575 Class A ordinary shares, each with a par value of USD0.025. Ucare operates a generative AI-powered, cloud-based platform for hospital and insurance risk management and is reported to be the only such platform currently operating in China. 

The acquisition is part of TRX’s strategic plan to expand its footprint in the health insurance market by leveraging Ucare’s existing infrastructure and technology. Ucare’s AI platform draws on real-time hospital data, medical guidelines, and clinical intelligence to help reduce fraud, abuse, waste, and administrative inefficiencies. With active relationships across more than 4,000 hospitals in China, Ucare is expected to assist TRX in developing new distribution channels and insurance service models. 

TIAN RUIXIANG is a Beijing-headquartered insurance broker that operates in China through a variable interest entity. It distributes a wide array of insurance products, including commercial property, liability, automobiles, accident, health, and life insurance. By integrating Ucare’s AI platform into its workflows, the company aims to improve pricing accuracy, streamline claims processing, and reduce operational costs in health insurance underwriting and administration. 

Ucare will continue to develop its AI capabilities using TRX’s platform and resources. The integration plan involves embedding generative AI into clinical and insurance decision-making processes, with a focus on expanding access and improving cost containment in the healthcare insurance landscape. According to both parties, the combined entity will target innovation across medical risk management and develop new approaches to aligning insurance design with healthcare delivery systems. 

The transaction reflects an industry trend of applying AI and real-time data analytics to traditional insurance operations, particularly in areas such as fraud detection, claim automation, and health risk assessment. TRX's acquisition of Ucare aims to build a unified insurance-hospital data framework that supports broader goals related to cost control and administrative efficiency top Bottom of Form.